Corient Private Wealth LP Makes New Investment in Inspire Medical Systems, Inc. $INSP

Key Points

• Corient Private Wealth initiated a position of 57,530 Inspire Medical Systems shares valued at approximately $2.57 million, while institutional investors and hedge funds collectively owned 94.91% of the company.
• Analyst sentiment remains mixed: Oppenheimer upgraded the stock to “outperform,” while Bank of America downgraded it to “underperform.” The consensus rating is “Hold,” with an average price target of $66.19.
• Inspire reported quarterly EPS of $0.14, beating expectations for a $0.24 loss, and revenue of $200.58 million, though revenue declined 7.6% year over year. The stock opened at $63.20, compared with a 12-month range of $38.91 to $147.03.

Corient Private Wealth LP bought a new position in shares of Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 57,530 shares of the company's stock, valued at approximately $2,567,000. Corient Private Wealth LP owned approximately 0.20% of Inspire Medical Systems at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Royal Bank of Canada raised its stake in shares of Inspire Medical Systems by 16.0% in the 1st quarter. Royal Bank of Canada now owns 32,769 shares of the company's stock valued at $5,220,000 after purchasing an additional 4,528 shares during the period. Integrated Wealth Concepts LLC bought a new position in shares of Inspire Medical Systems during the 1st quarter worth approximately $524,000. Goldman Sachs Group Inc. grew its stake in shares of Inspire Medical Systems by 57.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 51,422 shares of the company's stock worth $8,190,000 after acquiring an additional 18,857 shares in the last quarter. Marshall Wace LLP raised its holdings in shares of Inspire Medical Systems by 3.8% in the second quarter. Marshall Wace LLP now owns 15,905 shares of the company's stock valued at $2,064,000 after purchasing an additional 577 shares during the last quarter. Finally, Jump Financial LLC acquired a new stake in shares of Inspire Medical Systems in the second quarter valued at approximately $931,000. 94.91% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages recently commented on INSP. Evercore set a $54.00 target price on shares of Inspire Medical Systems in a report on Tuesday, August 4th. Oppenheimer upgraded shares of Inspire Medical Systems from a "market perform" rating to an "outperform" rating and set a $85.00 price target on the stock in a research note on Tuesday, August 4th. Bank of America cut shares of Inspire Medical Systems from a "neutral" rating to an "underperform" rating and set a $39.00 price target on the stock. in a research report on Friday, May 22nd. Summit Redstone set a $39.00 price objective on shares of Inspire Medical Systems in a research note on Friday, May 22nd. Finally, JPMorgan Chase & Co. raised their price objective on Inspire Medical Systems from $54.00 to $60.00 and gave the company a "neutral" rating in a report on Tuesday, August 4th. Two equities research analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating, eleven have issued a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat.com, Inspire Medical Systems currently has an average rating of "Hold" and a consensus target price of $66.19.

Insider Transactions at Inspire Medical Systems

In other Inspire Medical Systems news, insider Jason P. Kelly sold 963 shares of the firm's stock in a transaction on Friday, August 7th. The stock was sold at an average price of $59.55, for a total transaction of $57,346.65. Following the completion of the sale, the insider owned 18,985 shares of the company's stock, valued at $1,130,556.75. This trade represents a 4.83% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 2.20% of the stock is owned by corporate insiders.

Inspire Medical Systems Stock Up 2.7%

NYSE:INSP opened at $63.20 on Thursday. The stock's 50 day moving average price is $54.33 and its two-hundred day moving average price is $52.35. The firm has a market capitalization of $1.83 billion, a price-to-earnings ratio of 13.68, a P/E/G ratio of 4.68 and a beta of 0.70. Inspire Medical Systems, Inc. has a 12-month low of $38.91 and a 12-month high of $147.03.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last issued its earnings results on Monday, August 3rd. The company reported $0.14 EPS for the quarter, topping the consensus estimate of ($0.24) by $0.38. The company had revenue of $200.58 million during the quarter, compared to the consensus estimate of $194.72 million. Inspire Medical Systems had a return on equity of 8.64% and a net margin of 15.03%.The firm's revenue for the quarter was down 7.6% compared to the same quarter last year. During the same period in the previous year, the company posted $0.45 EPS. Inspire Medical Systems has set its FY 2026 guidance at 1.050-1.450 EPS. Equities research analysts expect that Inspire Medical Systems, Inc. will post 1.24 EPS for the current year.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company's flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.

Want to see what other hedge funds are holding INSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Inspire Medical Systems, Inc. (NYSE:INSP - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.